RUA Life Sciences

RUA · AIM · Health Care · mcap £19m · 29.5p

Beta Briefing, track record and bull & bear case are not ready for RUA Life Sciences yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 34 companies are already wired into a briefing: browse them.

Financials · LTM to 31 Mar 26

Source: results 30 Jun 26 ↗

Revenue: –
Operating profit: –
Net income: –
Free cash flow: –
Net cash: £2.4m
Market cap: £18.3m
EV / EBIT: –
FCF yield: –
Price / book: 2.6×

Latest half-year · H2 Mar 26 vs H2 Mar 25 results 30 Jun 26 ↗

Revenue: £2.7m
Operating profit: −£234k
Net income: −£201k
Cash from operations: −£758k

Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.

Income statement Cash flow Balance sheet

Annual Half-yearly

Latest report: H2 Mar 26 (six months to 31 Mar 26), published 30 Jun 26 · read the results ↗

£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source

	FY Mar 24
Depreciation (owned assets)	0.3
Amortisation	0.1
Share-based payments	(0.0)
EPS basic	(4.3p)
EPS diluted	(4.3p)

	H2 Mar 26	vs H2 Mar 25	H2 Mar 25
Revenue	2.7	+6%	2.6
Gross profit	2.1	+8%	1.9
Adjusted EBITDA	0.1	n/m	(0.2)
EBITDA	0.0	n/m	(0.4)
Operating profit	(0.2)	n/m	(0.7)
Depreciation (owned assets)	0.2	−7%	0.2
Amortisation	0.0	n/m	0.0
Share-based payments	0.1	n/m	0.1
Profit before tax	(0.2)	n/m	(0.6)
Tax	(0.0)	n/m	0.0
Net income (owners)	(0.2)	n/m	(0.6)
EPS basic	(0.3p)	–	(1.0p)
EPS diluted	(0.3p)	–	(1.0p)

	FY Mar 24
Interest paid	0.0
Capex (PP&E)	(0.1)
Shares issued	4.0

	H2 Mar 26	vs H2 Mar 25	H2 Mar 25
Cash from operations	(0.8)	n/m	0.0
Interest paid	(0.0)	n/m	(0.0)
Capex (PP&E)	(0.0)	n/m	(0.0)
Shares issued	0.0	n/m	0.0

	FY Mar 26	FY Mar 25	FY Mar 24
Goodwill	0.3	0.3	0.3
Other intangibles	0.3	0.4	0.4
Property, plant & equipment	2.9	3.2	2.5
Inventories	1.0	0.8	0.1
Trade receivables	1.8	1.1	0.9
Cash	2.4	3.6	3.9
Current assets	5.1	5.4	5.0
Total assets	8.6	9.3	8.2
Trade payables	0.7	0.7	0.4
Borrowings, current	0.0	0.2	0.0
Lease liabilities, current	0.2	0.2	0.1
Current liabilities	0.9	1.1	0.6
Borrowings, non-current	0.0	0.0	–
Lease liabilities, non-current	0.5	0.6	0.1
Total liabilities	1.6	1.9	1.0
Non-controlling interests	0.0	0.1	–
Total equity	7.0	7.4	7.2

	H2 Mar 26	H1 Sep 25	H2 Mar 25	H2 Mar 24
Goodwill	0.3	0.3	0.3	0.3
Other intangibles	0.3	0.3	0.4	0.4
Property, plant & equipment	2.9	3.1	3.2	2.5
Inventories	1.0	0.9	0.8	0.1
Trade receivables	1.8	1.2	1.1	0.9
Cash	2.4	3.2	3.6	3.9
Current assets	5.1	5.4	5.4	5.0
Total assets	8.6	9.1	9.3	8.2
Trade payables	0.7	0.9	0.7	0.4
Borrowings, current	0.0	0.1	0.2	0.0
Lease liabilities, current	0.2	0.2	0.2	0.1
Current liabilities	0.9	1.2	1.1	0.6
Borrowings, non-current	0.0	0.0	0.0	–
Lease liabilities, non-current	0.5	0.6	0.6	0.1
Total liabilities	1.6	1.9	1.9	1.0
Non-controlling interests	0.0	0.0	0.1	–
Total equity	7.0	7.2	7.4	7.2

Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.

Company filings. Not investment advice.